These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 35069731)
1. Analysis of Influencing Factors on the Occurrence and Development of Gastric Cancer in High-Incidence Areas of Digestive Tract Tumors Based on High Methylation of GPX3 Gene. Xie J; Fu L; Zhang J J Oncol; 2022; 2022():3094881. PubMed ID: 35069731 [TBL] [Abstract][Full Text] [Related]
2. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. Peng DF; Hu TL; Schneider BG; Chen Z; Xu ZK; El-Rifai W PLoS One; 2012; 7(10):e46214. PubMed ID: 23071548 [TBL] [Abstract][Full Text] [Related]
3. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749 [TBL] [Abstract][Full Text] [Related]
4. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785 [TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Peng DF; Razvi M; Chen H; Washington K; Roessner A; Schneider-Stock R; El-Rifai W Gut; 2009 Jan; 58(1):5-15. PubMed ID: 18664505 [TBL] [Abstract][Full Text] [Related]
6. GPX3 hypermethylation in gastric cancer and its prognostic value in patients aged over 60. Zhou C; Pan R; Li B; Huang T; Zhao J; Ying J; Duan S Future Oncol; 2019 Apr; 15(11):1279-1289. PubMed ID: 30924352 [TBL] [Abstract][Full Text] [Related]
8. GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia. Zhou JD; Yao DM; Zhang YY; Ma JC; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J Am J Cancer Res; 2015; 5(5):1786-94. PubMed ID: 26175946 [TBL] [Abstract][Full Text] [Related]
9. GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia. Zhou JD; Yao DM; Zhang YY; Ma JC; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J Am J Cancer Res; 2015; 5(6):2047-55. PubMed ID: 26269763 [TBL] [Abstract][Full Text] [Related]
10. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Lee OJ; Schneider-Stock R; McChesney PA; Kuester D; Roessner A; Vieth M; Moskaluk CA; El-Rifai W Neoplasia; 2005 Sep; 7(9):854-61. PubMed ID: 16229808 [TBL] [Abstract][Full Text] [Related]
11. Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer. Chen Z; Hu T; Zhu S; Mukaisho K; El-Rifai W; Peng DF Oncotarget; 2017 Aug; 8(33):54345-54356. PubMed ID: 28903346 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. Zhang X; Zheng Z; Yingji S; Kim H; Jin R; Renshu L; Lee DY; Roh MR; Yang S Oncol Rep; 2014 Jun; 31(6):2587-92. PubMed ID: 24788695 [TBL] [Abstract][Full Text] [Related]
13. GPX3 promoter is methylated in chronic myeloid leukemia. Yao DM; Zhou JD; Zhang YY; Yang L; Wen XM; Yang J; Guo H; Chen Q; Lin J; Qian J Int J Clin Exp Pathol; 2015; 8(6):6450-7. PubMed ID: 26261521 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis. Mohamed MM; Sabet S; Peng DF; Nouh MA; El-Shinawi M; El-Rifai W Oxid Med Cell Longev; 2014; 2014():787195. PubMed ID: 24790704 [TBL] [Abstract][Full Text] [Related]
15. Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma. Chen H; Zheng Z; Kim KY; Jin X; Roh MR; Jin Z Oncol Rep; 2016 Nov; 36(5):2737-2744. PubMed ID: 27600457 [TBL] [Abstract][Full Text] [Related]
16. Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer. Zhao H; Li J; Li X; Han C; Zhang Y; Zheng L; Guo M Curr Protein Pept Sci; 2015; 16(4):316-21. PubMed ID: 25929866 [TBL] [Abstract][Full Text] [Related]
17. Association between GPX3 promoter methylation and malignant tumors: A meta-analysis. Zhou C; Hu H; Zheng Z; Chen C; Li Y; Li B; Duan S Pathol Res Pract; 2019 Jul; 215(7):152443. PubMed ID: 31085009 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of somatostatin in gastric cancer. Jackson K; Soutto M; Peng D; Hu T; Marshal D; El-Rifai W Dig Dis Sci; 2011 Jan; 56(1):125-30. PubMed ID: 20927589 [TBL] [Abstract][Full Text] [Related]
19. Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma. Lin Y; Zhang Y; Chen Y; Liu Z Pathol Res Pract; 2019 Nov; 215(11):152676. PubMed ID: 31610903 [TBL] [Abstract][Full Text] [Related]
20. Association of COX2 gene hypomethylation with intestinal type gastric cancer in samples of patients from northern Brazil. de Melo CF; Gigek CO; da Silva JN; Cardoso Smith Mde A; de Araújo RM; Burbano RR; Lima EM Tumour Biol; 2014 Feb; 35(2):1107-11. PubMed ID: 24014049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]